Sains Malaysiana 52(12)(2023): 3475-3484
http://doi.org/10.17576/jsm-2023-5212-10
Relationship between Obesity and Infertility among Women with Polycystic Ovarian Syndrome Treated
at the National Population and Family Development Board (NPFDB) Malaysia
(Hubungan antara Keobesitian dan Ketidaksuburan dalam Kalangan Wanita dengan Sindrom Ovari Polisistik Dirawat di Lembaga Penduduk dan Pembangunan Keluarga Negara (LPPKN) Malaysia)
HASNOORINA HUSIN1,2,
MOHD AZIZUDDIN MOHD YUSSOF1, ASMAH HAMID2, ISMARULYUSDA
ISHAK2 & SITI BALKIS BUDIN3,*
1Biomedical Unit, Division of Human
Reproductive, National Population and Family Development Board, 12B, Jalan Raja Laut, 50350 Kuala
Lumpur, Malaysia
2Center for Toxicology and Health Risk,
Faculty of Health Sciences, Universiti Kebangsaan Malaysia, Kuala Lumpur Campus, Jalan Raja Muda Abdul Aziz, 50300
Kuala Lumpur, Malaysia
3Center
for Diagnostic, Therapeutic and Investigative, Studies,
Faculty of Health Sciences, Universiti Kebangsaan Malaysia, Kuala Lumpur Campus, Jalan Raja Muda Abdul Aziz,
50300 Kuala Lumpur, Malaysia
Diserahkan: 8 Disember 2023/Diterima: 18 Disember 2023
Abstract
Polycystic ovarian syndrome (PCOS) is a
metabolic dysfunction and is closely related to infertility in women. Obesity
has an impact on the clinical manifestations of PCOS. This study was designed
to determine the relationship between obesity and infertility among women with
PCOS treated at the National Population and Family Development Board (NPFDB)
Malaysia. This is a cross-sectional study with a simple random sampling technique involving infertile women attending NPFDB Subfertility Clinic, Kuala
Lumpur, Malaysia, from January 2018 to December 2019. Clinical and menstrual history were recorded, and
subjects underwent physical examination by a medical doctor. Subjects were diagnosed
with PCOS based on Rotterdam criteria, and blood was taken for
reproductive hormone, blood glucose, cholesterol, and triglyceride
determination. A total of 179 infertile women
completed the study, and 84 (47%) were diagnosed with PCOS. Results
showed a significant increase in follicle-stimulating
hormone (FSH) levels along with a significant
reduction in progesterone level (p<0.05) in PCOS women
compared to non-PCOS women. A total of 44% of PCOS women were found to be obese, and they exhibited
significantly higher blood pressure and triglyceride level but lower high-density lipoprotein (HDL) level (p<0.05). Chi-square (χ2) showed PCOS women who are obese are more likely to experience
ovulatory dysfunction, as evidenced by oligo- and amenorrhea, compared to
non-obese women with PCOS. In addition, they were also presented with
significantly higher testosterone levels (p<0.05) and reduced
progesterone levels compared to non-obese PCOS women. This
study showed that PCOS women with obesity had more prominent ovulatory dysfunction and reproductive hormonal
imbalance than non-obese PCOS women. These
findings suggest that PCOS women with obesity are more prone to develop
infertility.
Keywords: Infertility;
obesity; polycystic ovarian syndrome
Abstrak
Sindrom ovari polisistik (PCOS) adalah disfungsi metabolik dan berkait rapat dengan ketidaksuburan pada wanita. Keobesitian pula mempunyai kesan ke atas manifestasi klinikal PCOS. Kajian ini direka untuk menentukan hubungan antara keobesitian dan ketidaksuburan dalam kalangan wanita dengan PCOS yang dirawat di Lembaga Penduduk dan Pembangunan Keluarga Negara (LPPKN) di Malaysia. Kajian ini merupakan kajian keratan rentas dengan teknik persampelan rawak mudah melibatkan wanita tidak subur yang menghadiri Klinik Subfertiliti di LPPKN, Kuala Lumpur, Malaysia dari Januari 2018 hingga Disember 2019. Sejarah klinikal dan haid direkodkan dan subjek menjalani pemeriksaan fizikal oleh doktor perubatan. Subjek didiagnosi menghidap PCOS berdasarkan kriteria Rotterdam dan darah diambil untuk penentuan aras hormon reproduktif, glukosa, trigliserida dan kolesterol. Seramai 179 orang wanita tidak subur menyelesaikan kajian ini dan 84 (47%) daripadanya telah didiagnosis mengalami PCOS. Hasil kajian mendapati hormon perangsang folikel (FSH) adalah lebih tinggi dan progesteron adalah lebih rendah dengan ketara (p<0.05) pada wanita PCOS berbanding wanita tanpa PCOS. Seramai 44% wanita PCOS didapati obes dan mempunyai tekanan darah dan trigliserida yang lebih tinggi serta aras lipoprotein berketumpatan tinggi (HDL) lebih rendah dengan ketara (p<0.05). Khi kuasa dua (χ2) menunjukkan wanita PCOS yang mengalami obesiti mengalami disfungsi ovulasi yang ketara yang ditunjukkan oleh oligo dan amenorea berbanding wanita PCOS bukan obes. Tambahan pula, tahap testosteron adalah lebih tinggi secara signifikan (p<0.05) dan progesteron lebih rendah pada wanita PCOS yang obes. Sebagai kesimpulan kajian ini mendedahkan bahawa wanita PCOS dengan obesiti mempunyai disfungsi ovulasi dan ketidakseimbangan hormon reproduktif yang lebih ketara berbanding wanita PCOS bukan obes. Penemuan ini menunjukkan bahawa wanita PCOS dengan obesiti lebih cenderung untuk mengalami ketidaksuburan.
Kata kunci: Kobesitian; ketidaksuburan; sindrom ovari polisistik
RUJUKAN
Allahbadia, G.N. & Merchant, R. 2011. Polycystic
ovary syndrome and impact on health. Middle
East Fertility Society Journal 16(1): 19-37.
Aswini, R. & Sabeena Jayapalan. 2017. Modified Ferrimann Gallwey score in hirsutism and its association with metabolic syndrome. International Journal of Trichology 9(1): 7-13.
Barthelmess, E.K. & Naz,
R.K. 2015. Polycystic ovary syndrome: Current status and future perspective. Frontier in Bioscience (Elite Ed.) 6(1):
104-119.
Bee Koon Poh,
Boon Koon Ng, Mohd Din Siti Haslinda, Safii Nik Shanita, Jyh Eiin Wong, Siti Balkis Budin, Abdul Talib Ruzita, Lai Ong Ng, Ilse Khouw & A. Karim Narimah.
2013. Nutritional status and dietary intakes of
children aged 6 months to 12 years: Findings of the Nutrition Survey of
Malaysian Children (SEANUTS Malaysia). The British Journal of
Nutrition 110: 21-35.
Benksim, A., Elkhoudri,
N., Addi, R.A., Baali, A.
& Cherkaoui, M. 2018. Difference between primary
and secondary infertility in Morocco: Frequencies and associated factors. International
Journal of Fertility & Sterility 12(2): 142-146.
Best, D., Avenell, A. & Bhattacharya, S. 2017. How effective are
weight-loss interventions for improving fertility in women and men who are
overweight or obese? A systematic review and meta-analysis of the evidence. Human Reproductive Update 23(6):
681-705.
Borruel, S., Fernandez-Duran, E., Alpañés, M., Martí, D., Alvarez-Blasco, F. & Luque-Ramírez,
M. & Escobar-Morreale, H.F. 2013. Global
adiposity and thickness of intraperitoneal and mesenteric adipose tissue depots
are increased in women with polycystic ovary syndrome. Journal of Clinical Endocrinology Metabolism 98: 1254-1263.
Broughton, D.E. & Moley, K.H. 2017. Obesity and female infertility: Potential
mediators of obesity’s impact. Fertility
Sterility 107: 840-847.
Bruyneel, A., Catteau,
J.S., Decanter, C., Clouqueur, E., Tomaszewski, C. & Subtil, D.
2014. Polycystic ovary syndrome: What are the obstetrical risks? Gynecology Obstetric Fertility 42: 104-111.
Celik, C., Tasdemir,
N., Abali, R., Bastu, E.
& Yilmaz, M. 2014. Progression to impaired glucose tolerance or type 2
diabetes mellitus in polycystic ovary syndrome: A controlled follow-up study. Fertility Sterility 101(4):
1123-1128.e1.
Chong, C.T., Lai, W.K., Mohd Sallehuddin, S. & Ganapathy, S.S. 2023. Prevalence of overweight and its
associated factors among Malaysian adults: Findings from a nationally
representative survey. PLoS ONE 18(8): e0283270.
Daniilidis, A. & Dinas,
K. 2009. Long-term health consequences of polycystic ovarian syndrome: A review
analysis. Hippokratia 13(2): 90-92.
Deatsman, S., Vasilopoulos,
T. & Rhoton-Vlasak, A. 2016. Age and fertility: A
study on patient awareness. JBRA Assisted
Reproductive 20(3): 99-106.
Deshpande, P.S. & Gupta, A.S. 2019. Causes and
prevalence of factors causing infertility in a public health facility. Human Reproduction Science 12(4):
287-293.
Diamanti, K.E. & Dunaif,
A. 2012. Insulin resistance and the polycystic ovary syndrome revisited: An update on mechanisms and implications. Endocrinology Revision 33(6): 981-1030.
Diamanti, K.E., Xyrafis,
X., Boutzios, G. & Christakou,
C. 2008. Pancreatic beta-cells dysfunction in polycystic ovary syndrome. Panminerva Medicine 50(4): 315-325.
Dixon, D.L., Riche,
D.M. & Kelly, M.S. 2021. Chapter 32 Dyslipidemia.
In DiPiro’s Pharmacotherapy: A
Pathophysiological Approach. 12th ed., edited by DiPiro,
J.T., Yee, G.C., Haines, S.T., Nolin, T.D., Ellingrod,
V.L. & Posey, M. McGraw Hill.
Dunaif, A., Segal, K.R., Futterweit,
W. & Dobryansky, A. 2012. Profound peripheral
insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 38: 1165-1174.
Glintborg, D. & Andersen, M. 2010. An update on
the pathogenesis, inflammation, and metabolism in hirsutism and polycystic
ovary syndrome. Gynecology Endocrinology 26: 281-296.
Hart, R. & Doherty, D.A. 2015. The potential implications of a PCOS
diagnosis on a woman’s
long-term health using data linkage. Journal Clinical Endocrinology Metabolism 100:
911-919.
Haqq, L., Farlane,
J., Dieberg, G. & Smart, N. 2014. Effect of lifestyle
intervention on the reproductive endocrine profile in women with polycystic
ovarian syndrome: A systematic review and meta-analysis. Endocrine Connection 3(1): 36-46.
Institute for Public Health. 2020. National Health and
Morbidity Survey (NHMS).
https://iku.gov.my/images/IKU/Document/REPORT/2020/report/2_Report_NHMS2020_Vol-2.pdf
1: 18-3085-44207 Accessed 1 February 2022.
Jaacks, L.M., Vandevijvere,
S., Pan, A., McGowan, C.J., Wallace, C., Imamura, F., Mozaffarian,
D., Swinburn, B. & Ezzati,
M. 2019. The obesity transition: Stages of the global epidemic. Lancet Diabetes Endocrinology 7(3):
231-240.
Jabatan Statistik Malaysia. 2023.
Vital statistic Malaysia 2023. https://www.dosm.gov.my
Accessed 11 November 2023.
Komathy, T., Yusri Sham, Hasnoorina Husin, Norazlina Abdul Samad & Nor Hamizan Hashim. 2021. Laboratory
standard operation procedures. In Clinical Manual Management of
Subfertility, edited by Mohd Azizuddin.
Malaysia: National Population and Family Development Board (LPPKN). pp. 35-56.
Lungu, A.O., Zadeh,
E.S., Goodling, A., Cochran, E. & Gorden, P.
2012. Insulin resistance is a sufficient basis for hyperandrogenism in lipodystrophic women with polycystic ovarian
syndrome. Journal Clinical Endocrinology
Metabolism 97: 563-567.
Lyngs, J., Toft, G., Hoyer, B.B., Guldbrandsen, K., Olsen, J. & Ramalu,
H. 2014. Moderate alcohol intake and menstrual cycle characteristics. Human Reproduction 29: 351-358.
Mirza, F.G., Patki, A. & Pexman-Fieth, C. 2016. Dydrogesterone use in early pregnancy. Gynecological Endocrinology 32(2): 97-106.
MyGovernment. 2016. Demography of population
Malaysia. Department of Information, Government of Malaysia.
https://www.malaysia.gov.my/portal/content/30114 Accessed 9 May 2022.
Osibogun, O., Ogunmoroti,
O. & Michos, E.D. 2020. Polycystic
ovary syndrome and cardiometabolic risk:
Opportunities for cardiovascular disease prevention. Trend in Cardiovascular Medicine30(7): 399-404.
Palomba, S., Daolio, J.,
Romeo, S., Battaglia, F.A., Marci, R. & La Sala,
G.B. 2018. Lifestyle and fertility: The influence of stress and quality of life
on female fertility. 2018. Reproduction
Biology Endocrinology 16(1): 113.
Pandey, P., Maheshwari, A.
& Bhattacharya, S. 2010. Should access to fertility treatment be determined
by female body mass index? Human
Reproductive 25(4): 815-820.
Panidis, D., Macut, D., Tziomalos, K., Papadakis, E., Mikhailidis, K., Kandaraki, E.A. Tsourdi, E.A., Tantanasis, T., Mavromatidis, G. & Katsikis,
I. 2013. Prevalence of metabolic syndrome in women with polycystic ovary
syndrome. Clinical Endocrinology (Oxf) 78(4): 586-592.
Poh, B.K., Lee, S.T., Yeo, G.S., Tang, K.C.,
Noor Afifah, A.R., Siti Hanisa. A., Parikh, P., Wong, J.E., Ng, A.L.O. &
SEANUTS Study Group. 2019. Low socioeconomic status and severe obesity are
linked to poor cognitive performance in Malaysian children. BMC Public Health. 19(Suppl 4): 541.
Randeva, H.S., Tan, B.K., Weickert,
M.O., Lois, K., Nestler, J.E. & Sattar, N. 2012. Cardiometabolic aspects of the polycystic ovary syndrome. Endocrinology
Review 33: 812-841.
Reyes, M.E., Ortega, G.C., Martinez, C.N., Arcc, S.L., Estrada, G.G. & Moran, C. 2016. Association
of obesity and overweight with the prevalence of insulin resistance,
pre-diabetes and clinical-biochemical characteristics among infertile Mexican
women with polycystic ovary syndrome: A cross-sectional study. BMJ Open 6(7): 12107.
Robert, W. 2012. Dyslipidemia in PCOS. Steroids 77: 295-299.
Rotterdam ESHRE/ASRM-Sponsored PCOS
Consensus Workshop Group. 2004. Revised 2003 consensus on diagnostic criteria
and long-term health risks related to polycystic ovarian syndrome. Human Reproductive 19: 41-47.
Sangaraju, S.L., Yepez,
D., Grandes, X.A., Talanki Manjunatha, R. & Habib, S. 2022. Cardio-metabolic
disease and polycystic ovarian syndrome (PCOS): A narrative review. Cureus14(5): e25076.
Sareh Dashti, Latiffah Abdul Latiff, Habibah Abdul Hamid, Suriani Mohamed Saini, Azrin Shah Abu Bakar, Nur Amirah Inani Sabri, Maimunah Ismail & Ali Jafarzadeh Esfehani. 2019.
Prevalence of polycystic syndrome among Malaysian female university staff. Journal of Midwifery and Reproductive Health 7(1): 1560-1568.
Sidika, E.K. 2017. New biomarkers for diagnosis
and management of polycystic ovary syndrome. Clinica Chimica Acta 471: 248-253.
Sirmans, S.M. & Pate, K.A. 2014. Epidemiology,
diagnosis and management of polycystic ovary syndrome. Clinical Epidemiology 6: 1-13.
Teede, H., Deeks, A.
& Moran, L. 2010. Polycystic ovary syndrome: A complex condition with
psychological, reproductive and metabolic
manifestations that impact health across the lifespan. BMC Medicine 8(4): 1-10.
Teede, H.J., Misso,
M.L., Costello, M.F., Dokras, A., Laven,
J., Moran, L., Piltonen, T., Norman, R.J. &
International PCOS Network. 2018. Recommendation from the international
evidence-based guideline for the assessment and management of polycystic ovary
syndrome. Fertility Sterility 110(3):
364-379.
Vahratian, A. & Smith, Y.R. 2009. Should access
to fertility-related services be conditional on body mass index? Human Reproductive Update 24(7):
1532-1537.
Women’s Health, U.S. Department of Health and Human
Services. 2015. https://www.women-shealth.gov/publications/our-pub;ications/fact-sheet/polycystic-ovary-syndrome.pdf Accessed 23 February 2021.
*Pengarang untuk surat-menyurat; email: balkis@ukm.edu.my
|